First human tests begin for new Weight-Loss drug
NCT ID NCT06585462
Summary
This is an early-stage study to check if a new drug called AMG 513 is safe for people with obesity. It will involve about 80 adults and will test different doses to see how the body handles the drug. The main goal is to identify any side effects and understand how the drug behaves in the body before testing if it helps with weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anaheim Clinical Trials
RECRUITINGAnaheim, California, 92801, United States
-
Carilion Medical Center
RECRUITINGLake Forest, California, 92630, United States
-
Clinical Pharmacology of Miami, LLC
RECRUITINGMiami, Florida, 33172, United States
-
Fomat Medical Research
RECRUITINGOxnard, California, 93030, United States
-
Translational Clinical Research LLC
RECRUITINGAventura, Florida, 33180, United States
Conditions
Explore the condition pages connected to this study.